The Multiple Myeloma Treatment Market is expected to reach USD 26.5 billion at a CAGR of 4.2% during the forecast period 2022-2030. Multiple myeloma, a complex and incurable hematologic malignancy, poses significant challenges to patients and healthcare providers worldwide. However, recent years have witnessed remarkable strides in the development of novel therapies, reshaping the landscape of...